KR101953742B1 - 모발 손상 치료 또는 예방 방법 또는 모발 성장 촉진용 방법 - Google Patents

모발 손상 치료 또는 예방 방법 또는 모발 성장 촉진용 방법 Download PDF

Info

Publication number
KR101953742B1
KR101953742B1 KR1020187014347A KR20187014347A KR101953742B1 KR 101953742 B1 KR101953742 B1 KR 101953742B1 KR 1020187014347 A KR1020187014347 A KR 1020187014347A KR 20187014347 A KR20187014347 A KR 20187014347A KR 101953742 B1 KR101953742 B1 KR 101953742B1
Authority
KR
South Korea
Prior art keywords
hair
topical
midkine
hair loss
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020187014347A
Other languages
English (en)
Korean (ko)
Other versions
KR20180056814A (ko
Inventor
사다토시 사쿠마
마리아 하라츠
대런 존스
Original Assignee
어드밴젠 인터내셔널 피티와이 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010900771A external-priority patent/AU2010900771A0/en
Application filed by 어드밴젠 인터내셔널 피티와이 리미티드 filed Critical 어드밴젠 인터내셔널 피티와이 리미티드
Publication of KR20180056814A publication Critical patent/KR20180056814A/ko
Application granted granted Critical
Publication of KR101953742B1 publication Critical patent/KR101953742B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
KR1020187014347A 2010-02-24 2011-02-23 모발 손상 치료 또는 예방 방법 또는 모발 성장 촉진용 방법 Expired - Fee Related KR101953742B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2010900771 2010-02-24
AU2010900771A AU2010900771A0 (en) 2010-02-24 Method of treatment or prevention of hair loss or for the enhancement of hair growth
PCT/AU2011/000194 WO2011103624A1 (en) 2010-02-24 2011-02-23 Method of treatment or prevention of hair loss or for the enhancement of hair growth

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020127024615A Division KR20140017416A (ko) 2010-02-24 2011-02-23 모발 손상 치료 또는 예방 방법 또는 모발 성장 촉진용 방법

Publications (2)

Publication Number Publication Date
KR20180056814A KR20180056814A (ko) 2018-05-29
KR101953742B1 true KR101953742B1 (ko) 2019-03-04

Family

ID=44506072

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020187014347A Expired - Fee Related KR101953742B1 (ko) 2010-02-24 2011-02-23 모발 손상 치료 또는 예방 방법 또는 모발 성장 촉진용 방법
KR1020127024615A Withdrawn KR20140017416A (ko) 2010-02-24 2011-02-23 모발 손상 치료 또는 예방 방법 또는 모발 성장 촉진용 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020127024615A Withdrawn KR20140017416A (ko) 2010-02-24 2011-02-23 모발 손상 치료 또는 예방 방법 또는 모발 성장 촉진용 방법

Country Status (8)

Country Link
US (2) US20130067604A1 (cg-RX-API-DMAC7.html)
EP (1) EP2538963B8 (cg-RX-API-DMAC7.html)
JP (1) JP5850862B2 (cg-RX-API-DMAC7.html)
KR (2) KR101953742B1 (cg-RX-API-DMAC7.html)
CN (2) CN106075398A (cg-RX-API-DMAC7.html)
AU (1) AU2011220326B2 (cg-RX-API-DMAC7.html)
GB (1) GB2490854B (cg-RX-API-DMAC7.html)
WO (1) WO2011103624A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6193968B2 (ja) * 2012-03-21 2017-09-06 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 発毛を調節するための組成物および方法
KR101921246B1 (ko) * 2017-01-04 2018-11-22 주식회사 베스트앤퍼스트바이오텍 탈모 방지 및 양모를 위한 헤어 필러 조성물 및 그 제조 방법
FR3061656B1 (fr) * 2017-01-09 2019-05-24 Societe Industrielle Limousine D'application Biologique Hydrolysat de pichia minuta et utilisation cosmetique pour lutter contre la chute des cheveux et favoriser leur repousse
CN108014328A (zh) * 2017-12-19 2018-05-11 吴广印 一种预防脱发、促进生发物质的配方及其制备方法
CN111991413B (zh) * 2020-09-18 2021-10-08 中国人民解放军陆军特色医学中心 一种预防脱发或促进毛发生长的多糖组合物及其制剂和应用
US20240269240A1 (en) * 2023-02-15 2024-08-15 Blue Blood Biotech Corporation Compositions and methods for treating hair loss or facilitating hair growth

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030202960A1 (en) 1998-04-17 2003-10-30 Colley Kenneth J. Therapeutic angiogenic factors and methods for their use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139619A (en) 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
JPH04224522A (ja) * 1990-04-27 1992-08-13 Merck & Co Inc 繊維芽細胞増殖因子含有組成物による禿頭症の治療又は予防方法
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
JPH05124935A (ja) * 1991-10-31 1993-05-21 Kao Corp 毛成長促進剤
US5767152A (en) * 1995-05-04 1998-06-16 Nielsen; Thor Bagger Composition and methods for stimulating hair growth
JPH09157183A (ja) * 1995-12-07 1997-06-17 Meiji Milk Prod Co Ltd 皮膚外用剤
JP3667027B2 (ja) * 1997-03-06 2005-07-06 株式会社ノエビア 皮膚外用剤
JPH10251158A (ja) * 1997-03-06 1998-09-22 Noevir Co Ltd 皮膚外用剤
CN1331155A (zh) * 2000-06-28 2002-01-16 上海博德基因开发有限公司 一种新的多肽——人肝素结合生长因子受体K-ram9.13和编码这种多肽的多核苷酸
US20030215412A1 (en) * 2000-07-21 2003-11-20 Essentia Biosystems, Inc. Induction of hair growth with vascular endothelial growth factor
AU2003216389A1 (en) * 2002-02-21 2003-09-09 Essentia Biosystems, Inc. Induction of hair growth with vascular endothelial growth factor
WO2005001044A2 (en) * 2003-05-29 2005-01-06 Angiogenix, Inc. Compositions related to pleiotrophin methods and uses thereof
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
CN1917878A (zh) * 2004-02-12 2007-02-21 沃尼尔·朗伯有限责任公司 刺激毛发生长的方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030202960A1 (en) 1998-04-17 2003-10-30 Colley Kenneth J. Therapeutic angiogenic factors and methods for their use

Also Published As

Publication number Publication date
KR20140017416A (ko) 2014-02-11
CN102791284A (zh) 2012-11-21
GB2490854B (en) 2014-07-16
GB201216817D0 (en) 2012-11-07
US9622955B2 (en) 2017-04-18
EP2538963B1 (en) 2017-05-17
AU2011220326A1 (en) 2012-08-23
KR20180056814A (ko) 2018-05-29
US20150044139A1 (en) 2015-02-12
EP2538963A1 (en) 2013-01-02
EP2538963B8 (en) 2017-08-02
WO2011103624A1 (en) 2011-09-01
EP2538963A4 (en) 2013-09-11
JP2013520447A (ja) 2013-06-06
US20130067604A1 (en) 2013-03-14
AU2011220326B2 (en) 2014-11-20
GB2490854A (en) 2012-11-14
CN106075398A (zh) 2016-11-09
JP5850862B2 (ja) 2016-02-03

Similar Documents

Publication Publication Date Title
JP4229842B2 (ja) L−アルギニンオリゴマーを含む化粧品処方
TWI652066B (zh) 用於使皮膚回春之胜肽及其使用方法
US9622955B2 (en) Method of treatment or prevention of hair loss or for the enhancement of hair growth
TWI862641B (zh) 具有抗老化功效之多肽及其用途
JP7733226B2 (ja) 抗老化活性を有するペプチド及びその用途
JP7733230B2 (ja) 抗老化活性を有するペプチド及びその用途
JP2025061604A (ja) タンパク質糖化抑制剤
JP5685315B2 (ja) ニコチン酸アデニンディヌクレオチドリン酸又はその誘導体を含む薬学又は化粧料組成物
JP2022183376A (ja) Cnp環状ペプチド並びに該環状ペプチドを含む医薬品、外用剤および化粧料
JP5216414B2 (ja) 育毛剤
KR20180010267A (ko) 환상 펩티드 및 그 환상 펩티드를 포함한 의약, 외용제 및 화장료
JP5166116B2 (ja) 育毛剤
EP3936138A1 (en) Pharmaceutical composition for the treatment of vitiligo
JP7733227B2 (ja) 抗老化活性を有するペプチド及びその用途
KR102954347B1 (ko) 발모 촉진 및 탈모 억제 활성을 가지는 펩타이드 및 이의 용도
KR102511527B1 (ko) 칠엽수 추출물을 포함하는 조성물
KR102932582B1 (ko) E2f를 유효성분으로 포함하고 상처치유 및 항노화 기능을 갖는 피부 치료용 연고 및 화장품 조성물
HK1178788A (en) Method of treatment or prevention of hair loss or for the enhancement of hair growth
JP7817720B2 (ja) ニキビ改善用組成物
CN120035599B (zh) 具有促进毛发生长和抑制毛发脱落活性的肽及其用途
KR102775224B1 (ko) 항산화, 미백, 항염증, 피부보호 등의 기능을 갖는 락토페린 유도체 제조방법 및 이를 포함하는 피부 치료용 연고 및 화장품 조성물
EP4385515A1 (en) Composition for skin repigmentation
KR20260020301A (ko) 펩타이드를 유효성분으로 포함하는 피부상태 개선용 조성물
JP2016037453A (ja) 皮膚保湿剤
HK40112226A (en) Composition for skin repigmentation

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A16-div-PA0104

St.27 status event code: A-0-1-A10-A18-div-PA0104

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

Fee payment year number: 1

St.27 status event code: A-2-2-U10-U12-oth-PR1002

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PC1903 Unpaid annual fee

Not in force date: 20220226

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

St.27 status event code: A-4-4-U10-U13-oth-PC1903

PC1903 Unpaid annual fee

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20220226

St.27 status event code: N-4-6-H10-H13-oth-PC1903